Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

PLX2853 in Combination With Abiraterone Acetate and Prednisone and in Combination With Olaparib in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04556617
Recruitment Status : Recruiting
First Posted : September 21, 2020
Last Update Posted : March 25, 2021
Sponsor:
Information provided by (Responsible Party):
Plexxikon

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : February 28, 2023
Estimated Study Completion Date : March 30, 2023